Plaque · People undergoing orthodontic treatment (any age; 9 to 34 years in included studies)
Long-term fluoride mouthwash showed mixed plaque-index effects, with very low-certainty evidence.
2 findings from 1 review
PI was similar to blank control [37]; API was slightly reduced compared to blank control and significant at 6 and 9 months [59].
2 studies
Very low
TI was significantly reduced compared to baseline [34]; PI was significantly reduced compared to baseline but similar to blank control [46].
2 studies
Very low
Cariogenic bacteria (Lactobacilli colony count) · Orthodontic patients (any age) undergoing orthodontic treatment (mostly fixed appliances)
Long-term (>=12 months) fluoride mouthwash may make little or no difference to Lactobacilli colony counts versus blank control (very low certainty).
1 finding from 1 review
Gingival index (GI) · Orthodontic patients (any age) undergoing orthodontic treatment (mostly fixed appliances)
Chlorhexidine mouthwash may reduce the Gingival Index versus blank control in the short term (WMD -0.54, 95% CI -0.96 to -0.13), but with very high heterogeneity the evidence is very uncertain (very low certainty).
1 finding from 1 review
Gingival inflammation-related index · People undergoing orthodontic treatment (any age; 9 to 34 years in included studies)
Herbal mouthwash reduced gingival inflammation-related indices versus placebo, but certainty is very low.
1 finding from 1 review
FEV1 (% predicted): mean change from baseline · adults and children with cystic fibrosis
1 finding from 1 review
FEF25–75: rate of decline in FEF25–75 · adults and children with cystic fibrosis
1 finding from 1 review
Time to first exacerbation requiring intravenous antibiotics · adults and children with cystic fibrosis
1 finding from 1 review
QoL · adults and children with cystic fibrosis
1 finding from 1 review
Adherence to therapy and individual preference · adults and children with cystic fibrosis
1 finding from 1 review
Mucus weight · adults and children with cystic fibrosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Annual rate of change in % predicted FEV1 All participants · adults and children with cystic fibrosis
It is very uncertain whether CCPT changes FEV1: annual decline in FEV1 % predicted compared with ACBT (very low certainty).
1 finding from 1 review
Annual rate of change in % predicted FVC Subgroup: Under 13 years of age · adults and children with cystic fibrosis
It is very uncertain whether CCPT changes FVC: annual decline in FVC % predicted compared with ACBT (very low certainty).
1 finding from 1 review
FEF25–75: annual decline in FEF25–75 % predicted · adults and children with cystic fibrosis
It is very uncertain whether CCPT changes FEF25–75: annual decline in FEF25–75 % predicted compared with ACBT (very low certainty).
1 finding from 1 review
Respiratory exacerbations: time to first exacerbation · adults and children with cystic fibrosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
QoL · adults and children with cystic fibrosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
FVC (% predicted) Change from baseline · adults and children with cystic fibrosis
1 finding from 1 review
Adherence to therapy and individual preference · adults and children with cystic fibrosis
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Mucus weight · adults and children with cystic fibrosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
FEV1 % predicted · adults and children with cystic fibrosis
1 finding from 1 review
FVC · adults and children with cystic fibrosis
1 finding from 1 review